
Jody M Mason
Articles
-
3 weeks ago |
biorxiv.org | Andrew Brennan |Jody M Mason
AbstractGenetically encoded peptide library screening is a powerful strategy for discovering inhibitors of protein-protein and protein-DNA interactions. The Transcription Block Survival (TBS) assay enables the in vivo selection of peptides that antagonise transcription factor (TF) binding by linking inhibition of DNA-binding to E.coli survival. However, previous TBS implementations required laborious re-engineering of the mDHFR coding region for each new target, limiting utility.
-
Oct 15, 2024 |
waste360.com | Jody M Mason |Stefanie Valentic
“We extend our profound appreciation to Rickey for his steadfast dedication and exceptional leadership, which have“We extend our profound appreciation to Rickey for his steadfast dedication and exceptional leadership, which have“We extend our profound appreciation to Rickey for his steadfast dedication and exceptional leadership, which have“We extend our profo
-
Oct 15, 2024 |
waste360.com | Jody M Mason |Stefanie Valentic
“We extend our profound appreciation to Rickey for his steadfast dedication and exceptional leadership, which have been instrumental in fostering our growth and success here at CWT,” “We extend our profound appreciation to Rickey for his steadfast dedication and exceptional leadership, which have been instrumental in fostering our growth and success here at CWT,”
-
Apr 15, 2024 |
waste360.com | Jody M Mason |Stefanie Valentic
Stay in the Know - Subscribe to Our NewslettersJoin a network of more than 90,000 waste and recycling industry professionals. Get the latest news and insights straight to your inbox. Free. Sign Me Up
-
Jul 6, 2023 |
nature.com | Jody M Mason
AbstractParkinson’s is the second most common neurodegenerative disease, with the number of individuals susceptible due to increase as a result of increasing life expectancy and a growing worldwide population. However, despite the number of individuals affected, all current treatments for PD are symptomatic—they alleviate symptoms, but do not slow disease progression.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →